EU Meeting Performance Goals For New Drug Review, But Lags Behind U.S. In New Drug Availability - Tufts CSDD Study

... Review times for new drugs in the European Union have met mandated performance goals, but many medicines are available in the United States prior to the EU, according to a study recently completed by the Tufts Center for the Study of Drug Development.The study found that mean approval times for new products approved in both the EU and the U.S. during 2000-05 were nearly identical: 15. [click link for full article] ...